Cargando…
Feasibility and tolerability of multimodal peripheral electrophysiological techniques in a cohort of patients with spinal muscular atrophy
OBJECTIVE: Electrophysiological techniques are emerging as an aid in identifying prognostic or therapeutic biomarkers in patients with spinal muscular atrophy (SMA), but electrophysiological assessments may be burdensome for patients. We, therefore, assessed feasibility and tolerability of multimoda...
Autores principales: | Ros, Leandra A.A., Sleutjes, Boudewijn T.H.M., Stikvoort García, Diederik J.L., Goedee, H. Stephan, Asselman, Fay-Lynn, van den Berg, Leonard H., van der Pol, W. Ludo, Wadman, Renske I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404501/ https://www.ncbi.nlm.nih.gov/pubmed/37554725 http://dx.doi.org/10.1016/j.cnp.2023.06.001 |
Ejemplares similares
-
Longitudinal prospective cohort study to assess peripheral motor function with extensive electrophysiological techniques in patients with Spinal Muscular Atrophy (SMA): the SMA Motor Map protocol
por: Ros, Leandra A. A., et al.
Publicado: (2023) -
Quantification of disease progression in spinal muscular atrophy with muscle MRI—a pilot study
por: Otto, Louise A.M., et al.
Publicado: (2021) -
Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2–4 (SPACE trial)
por: Stam, Marloes, et al.
Publicado: (2018) -
Natural history of lung function in spinal muscular atrophy
por: Wijngaarde, Camiel A., et al.
Publicado: (2020) -
Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2–4
por: Stam, Marloes, et al.
Publicado: (2022)